Literature DB >> 9013399

Alpha-helical CRF blocks differential influence of corticotropin releasing factor (CRF) on appetitive and aversive memory retrieval in rats.

K B Kumar1, K S Karanth.   

Abstract

This study examined whether corticotropin releasing factor (CRF), given prior to test, would produce an improved retrieval of aversive memory in the same way as pre-exposure to inescapable footshocks and the CRF antagonist, alpha-helical CRF 9-41 (a-h CRF), blocks this effect in rats. For this purpose animals conditioned in a T-maze with appetitive (10% sucrose) and aversive (2.0mA footshock) events were given intracerebroventricularly (i.c.v.) 20 min before testing, a single dose of 0.05, 0.1, 0.2 or 0.4 microgram/rat of CRF, or 5 micrograms/rat of a-h CRF, or both at 10 min interval. In the retention test conducted with the same training apparatus 72-hr after conditioning, CRF (0.05, 0.1 and 0.2 microgram) treated rats showed a dose-dependent increase in latencies to enter the previously shocked goalarm, with the absence of such a difference in responding to the nonshocked goalarm. The highest dose of CRF (0.4 microgram), however, increased the latencies to enter both the goalboxes. Alpha-helical CRF, administered 10 min before, antagonized the memory-enhancing effect of CRF. Further, CRF (0.1, 0.2 and 0.4 microgram) significantly decreased the total number of center entries in the open field, consistent with the view that i.c.v. administered CRF produces "anxiogenic-like" effect. Alpha-helical CRF reversed this effect. The effect of CRF on memory retrieval was similar to that seen following inescapable footshock in rats. The results thus suggest the possible involvement of central CRF mechanisms in the differential enhancement of memory of helplessness condition.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9013399     DOI: 10.1007/BF01291796

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  37 in total

1.  Effects of ACTH and ACTH 4-10 on aversive memory retrieval in rats.

Authors:  K B Kumar; K S Karanth
Journal:  J Neural Transm Gen Sect       Date:  1995

Review 2.  Physiology and pharmacology of corticotropin-releasing factor.

Authors:  M J Owens; C B Nemeroff
Journal:  Pharmacol Rev       Date:  1991-12       Impact factor: 25.468

3.  Differential influences of corticotropin-releasing factor on memory retention of aversive learning and appetitive learning in rats.

Authors:  E H Lee; Y J Sung
Journal:  Behav Neural Biol       Date:  1989-11

4.  Corticotropin-releasing factor administration elicits a stress-like activation of cerebral catecholaminergic systems.

Authors:  A J Dunn; C W Berridge
Journal:  Pharmacol Biochem Behav       Date:  1987-08       Impact factor: 3.533

5.  Effect of two ACTH-analogs on noradrenaline metabolism in rat brain.

Authors:  D H Versteeg
Journal:  Brain Res       Date:  1973-01-30       Impact factor: 3.252

6.  Corticotropin-releasing factor and behavior.

Authors:  G F Koob; F E Bloom
Journal:  Fed Proc       Date:  1985-01

Review 7.  Nucleus locus ceruleus: new evidence of anatomical and physiological specificity.

Authors:  S L Foote; F E Bloom; G Aston-Jones
Journal:  Physiol Rev       Date:  1983-07       Impact factor: 37.312

8.  Corticotropin-releasing factor activates noradrenergic neurons of the locus coeruleus.

Authors:  R J Valentino; S L Foote; G Aston-Jones
Journal:  Brain Res       Date:  1983-07-04       Impact factor: 3.252

9.  Corticotropin releasing factor produces behavioural activation in rats.

Authors:  R E Sutton; G F Koob; M Le Moal; J Rivier; W Vale
Journal:  Nature       Date:  1982-05-27       Impact factor: 49.962

Review 10.  The neuropsychology and neuropharmacology of the dorsal ascending noradrenergic bundle--a review.

Authors:  N McNaughton; S T Mason
Journal:  Prog Neurobiol       Date:  1980       Impact factor: 11.685

View more
  6 in total

1.  A functional continuum of regulatory anxiety-enhancing peptides. The search for complexes providing the optimal basis for developing inhibitory therapeutic agents.

Authors:  S V Koroleva; I P Ashmarin
Journal:  Neurosci Behav Physiol       Date:  2006-02

2.  Corticotropin releasing factor antagonist, alpha-helical CRF(9-41), reverses nicotine-induced conditioned, but not unconditioned, anxiety.

Authors:  Sonia Tucci; Survjit Cheeta; Pallab Seth; Sandra E File
Journal:  Psychopharmacology (Berl)       Date:  2003-04-01       Impact factor: 4.530

3.  Contrasting effects of pretraining, posttraining, and pretesting infusions of corticotropin-releasing factor into the lateral amygdala: attenuation of fear memory formation but facilitation of its expression.

Authors:  Koichi Isogawa; David E A Bush; Joseph E LeDoux
Journal:  Biol Psychiatry       Date:  2012-10-01       Impact factor: 13.382

4.  Neuronal mechanisms of increased accessibility of unpleasant memories in helpless rats - a summary of present findings and implication.

Authors:  K B Kumar; K S Karanth
Journal:  Indian J Psychiatry       Date:  1999-07       Impact factor: 1.759

5.  Involvement of stress-released corticotropin-releasing hormone in the basolateral amygdala in regulating memory consolidation.

Authors:  Benno Roozendaal; Kristen L Brunson; Brian L Holloway; James L McGaugh; Tallie Z Baram
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-02       Impact factor: 11.205

Review 6.  Neuromodulatory signaling in hippocampus-dependent memory retrieval.

Authors:  Steven A Thomas
Journal:  Hippocampus       Date:  2015-04       Impact factor: 3.753

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.